
|Articles|March 1, 2003
Blocking VEGF may be beneficial in diabetic macular edema
Orlando-The involvement of vascular endothelial growth factor (VEGF), also known as vascular permeability factor, in vascular permeability is a relatively newly recognized role. Blocking the up-regulation of VEGF seems to be a promising avenue of research in the prevention and treatment of diabetic macular edema (DME).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Rayner’s RayOne EMV Toric intraocular lens
2
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
3
NeuroOp Guru: When proptosis isn’t thyroid eye disease
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5